Global Biosimilars Market Report 2023-2028: Reimbursement and Payer Landscape Influence Biosimilar Adoption

DUBLIN, Dec. 4, 2023 /PRNewswire/ — The “Growth Opportunities in Global Biosimilars Market, Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

This study presents overall market and segment-wise revenue forecasts for the global biosimilars market. It highlights key growth opportunities for biosimilar market participants based on the trends, evolution of business models, and strategic imperatives for various stakeholders. It identifies the greatest revenue-generating therapeutic areas and product types.

Biosimilar acceptance and use are increasing as patients and healthcare providers improve their understanding and awareness of therapeutic agents driven by biosimilar manufacturers and regulators. As the availability of information and practical data supporting the safety and effectiveness of biosimilars increases, both patients and healthcare professionals are developing a greater level of confidence in these medications.

It is imperative for pharmaceutical companies to delicately navigate the intricate balance between safeguarding their biologic products and cultivating an environment conducive to the presence of biosimilars, which inevitably contribute to a thriving competitive milieu.

The elements affecting regional biosimilar uptake and biosimilar market entrance have been clearly stated. In addition, this report covers complicated factors, including reimbursement and payer landscape, biosimilar price trends, and biosimilar sales trends that will affect biosimilar penetration. The study discusses regional biosimilar discrepancies as well as industry issues, including physician adoption and patent litigations.

This report identifies key growth opportunities to increase biosimilar uptake and innovations and compete for newer therapy areas, such as neurology and oncology.

Key Topics Covered:

1. Strategic Imperatives

Why is it Increasingly Difficult to Grow?The Strategic ImperativeThe Impact of the Top 3 Strategic Imperatives on the Global Biosimilars MarketGrowth Opportunities Fuel the Growth Pipeline Engine

2. Growth Opportunity Analysis

Scope of AnalysisMarket SegmentationKey Regional Competitors in the Biosimilars MarketGrowth DriversGrowth Restraints

3. Growth Environment – Biosimilars Market

Highlights – Biosimilars Regional DynamicsGrowth Opportunities – Biosimilars MarketStrategies to Boost Biosimilars Development and AdoptionBiopharma Taking Lead to Boost Adoption of Biosimilars – SandozNorth America Competitive Benchmarking – Key CountriesMarket Snapshot – US Biosimilar MarketBiosimilars Approved in the USThe US Healthcare Financial and Distribution PathwaysBusiness Model Transformation due to the Next Wave of BiosimilarsEvolving Roles of PBM Formularies to Boost Biosimilar AccessibilityEvolving US Biosimilar Regulatory LandscapeUS Insulin Biosimilar Market Set for Major Reset in Response to IRADual Pricing Strategy in the USUS OncologyUS Oncology Supportive CareUS Immunology and OphthalmologyEurope Competitive Benchmarking – Key CountriesMarket Snapshot – Europe Biosimilars MarketBiosimilars Approved in EuropeSwift and Rapid Adoption of Biosimilar – Denmark Success StoryIncentives Driving Adoption of BiosimilarsAPAC and MEA Competitive Benchmarking – Key CountriesMarket Snapshot – Key APAC and MEA Biosimilar MarketIntensifying Focus of Asian Biopharma and CDMO on the Global Market

4. Growth Opportunity Analysis – Biosimilars Industry

Key Growth MetricsForecast Assumptions and Considerations – Biosimilars MarketRevenue Forecast – Global Biosimilars MarketRevenue Forecast Analysis – Global Biosimilars MarketRevenue Forecast by Product TypeRevenue Forecast Analysis by Product TypeRevenue Forecast by Therapeutic AreaNew and Upcoming Key Biologics Patent ExpirationRevenue Forecast Analysis – OncologyRevenue Forecast Analysis – Musculoskeletal and ImmunologyRevenue Forecast Analysis – Endocrinology and OphthalmologyCompetitive EnvironmentRevenue shareRevenue Share Analysis

5. Growth Opportunity Universe

Growth Opportunity 1: RWE SolutionsGrowth Opportunity 2: Neurology BiosimilarsGrowth Opportunity 3: Focus on the Middle East and AfricaGrowth Opportunity 4: Leveraging AI, PD, and Omics BiomarkersGrowth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars

For more information about this report visit https://www.researchandmarkets.com/r/uhgwoc

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-biosimilars-market-report-2023-2028-reimbursement-and-payer-landscape-influence-biosimilar-adoption-302004646.html

SOURCE Research and Markets